Tinoco G - Search Results

1

Association of Combination of Conformation-Specific KIT Inhibitors With Clinical Benefit in Patients With Refractory Gastrointestinal Stromal Tumors: A Phase 1b/2a Nonrandomized Clinical Trial.

Wagner AJ, Severson PL, Shields AF, Patnaik A, Chugh R, Tinoco G, Wu G, Nespi M, Lin J, Zhang Y, Ewing T, Habets G, Burton EA, Matusow B, Tsai J, Tsang G, Shellooe R, Carias H, Chan K, Rezaei H, Sanftner L, Marimuthu A, Spevak W, Ibrahim PN, Inokuchi K, Alcantar O, Michelson G, Tsiatis AC, Zhang C, Bollag G, Trent JC, Tap WD. Wagner AJ, et al. Among authors: tinoco g. JAMA Oncol. 2021 Sep 1;7(9):1343-1350. doi: 10.1001/jamaoncol.2021.2086. JAMA Oncol. 2021. PMID: 34236401 Free PMC article. Clinical Trial.

2

Sinonasal teratocarcinosarcoma: a therapeutic dilemma.

Peralta Suarez G, Dibs K, Carrau RL, Schoenfield L, Blakaj DM, Tinoco G. Peralta Suarez G, et al. Among authors: tinoco g. BMJ Case Rep. 2022 Nov 25;15(11):e252429. doi: 10.1136/bcr-2022-252429. BMJ Case Rep. 2022. PMID: 36428033 Free PMC article.

3

The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase.

Tinoco G, Wilky BA, Paz-Mejia A, Rosenberg A, Trent JC. Tinoco G, et al. Am Soc Clin Oncol Educ Book. 2015:e648-55. doi: 10.14694/EdBook_AM.2015.35.e648. Am Soc Clin Oncol Educ Book. 2015. PMID: 25993236 Free article. Review.

4

Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells.

Li L, Paz AC, Wilky BA, Johnson B, Galoian K, Rosenberg A, Hu G, Tinoco G, Bodamer O, Trent JC. Li L, et al. Among authors: tinoco g. PLoS One. 2015 Sep 14;10(9):e0133813. doi: 10.1371/journal.pone.0133813. eCollection 2015. PLoS One. 2015. PMID: 26368816 Free PMC article.

5

A precision medicine approach in sarcoma: identification of patients who may benefit from early use of pazopanib.

Alavi SN, Florou V, Tinoco G, Trent JC, Wilky BA. Alavi SN, et al. Among authors: tinoco g. Discov Med. 2018 Mar;25(137):131-144. Discov Med. 2018. PMID: 29641974 Free article. Review.

6

[No title available]

[No authors listed] [No authors listed] PMID: 37785176

7

Association of Programmed Cell Death 1 Inhibitor With Circumorificial Plasmacytosis.

Korman AM, Zyniewicz K, Tinoco G, Allen CM, Briody A. Korman AM, et al. Among authors: tinoco g. JAMA Dermatol. 2021 Feb 1;157(2):237-238. doi: 10.1001/jamadermatol.2020.4273. JAMA Dermatol. 2021. PMID: 33326007 No abstract available.

8

Larotrectinib in a Patient With Advanced Pleomorphic Liposarcoma of the Uterus.

Valenciaga A, Iwenofu OH, Tinoco G. Valenciaga A, et al. Among authors: tinoco g. J Natl Compr Canc Netw. 2021 Jul 28;19(7):775-779. doi: 10.6004/jnccn.2021.7039. J Natl Compr Canc Netw. 2021. PMID: 34340207

9

Case report: The power of immunotherapy in advanced cutaneous squamous cell carcinoma.

Brockwell M, Husain M, Verschraegen C, Wu R, Tinoco G. Brockwell M, et al. Among authors: tinoco g. Front Oncol. 2023 Jan 4;12:1081118. doi: 10.3389/fonc.2022.1081118. eCollection 2022. Front Oncol. 2023. PMID: 36686737 Free PMC article.

10

Treating breast cancer in the 21st century: emerging biological therapies.

Tinoco G, Warsch S, Glück S, Avancha K, Montero AJ. Tinoco G, et al. J Cancer. 2013;4(2):117-32. doi: 10.7150/jca.4925. Epub 2013 Jan 11. J Cancer. 2013. PMID: 23386910 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters